FITC - anti Human, Feline (cat), Rabbit CD81 - M38

FITC - anti Human, Feline (cat), Rabbit CD81 - M38

Catalog Number:
A001108899IMM
Mfr. No.:
81F-100T
Price:
$780
  • Size:
    100 test
    Quantity:
    Add to Cart:
      • Overview
        • This antibody reacts with the CD81-antigen, which is a widely expressed cell-surface protein involved in an astonishing variety of biologic responses. It has been cloned independently several times for different functional effects and is reported to influence adhesion, morphology, activation, proliferation, and differentiation of B, T, and other cells. On B cells CD81 is part of a complex with CD21, CD19, and Leu13. This complex reduces the threshold for B cell activation via the B cell receptor by bridging Ag specific recognition and CD21-mediated complement recognition. Similarly on T cells CD81 associates with CD4 and CD8 and provides a costimulatory signal with CD3. CD81 is also physically and functionally associated with several integrins. Anti-CD81 can activate integrin alpha 4 beta 1 (VLA-4) on B cells, facilitating their adhesion to tonsilar interfollicular stroma.

          Please contact us at for specific academic pricing.

      • Properties
        • Isotype
          IgG1
          Reactivity
          human; cat; rabbit
          Clone
          M38
          Immunogen
          MOLT-4 (human T-ALL cell line)
          Conjugate
          FITC
          Concentration
          Please refer to the Certificate of Analysis for the lot-specific concentration.
          Regulatory Status
          RUO
          Antigen
          (Gene ID:975)

          * For research use only.

      • Applications
        • Application
          Flow Cytometry
          Application Description
          CD81, clone M38, is a mAb intended for identification of TAPA-1. This reagent is effective for direct IF staining of human tissue for FCM analysis using ≤1 μg/106 cells.

    Note: If you don't receive our verification email, do the following:

    Copyright © Amerigo Scientific. All rights reserved.